IDEAYA Biosciences (IDYA)
Develops biomarker-selected cancer drugs across small molecules and antibody-drug conjugates.
$38.19
vs last close−1.52 (−3.83%)
Something off on this page? Send us feedback.
Next report
Nov 9, 26
estimated · in 47 days
EPS estimate
−$1.18
Revenue estimate
$6.8M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported−$1.49−$0.82−$0.88$1.33−$0.94−$1.11−$1.22Pending
Estimate−$0.67−$0.75−$0.85−$0.95−$0.95−$1.07−$1.06−$1.18
Surprise−122.4%−9.3%−3.5%+240.6%+1.2%−3.7%−15.1%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$7.0M——$207.8M$10.9M$6.6M$8.9MPending
Estimate$2.5M$2.4M$2.0M$5.9M$6.3M$5.0M$8.0M$6.8M
Surprise+180.6%——+3,395.1%+72.5%+30.2%+10.4%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.86 | — | — |
| Sep 2027 | −$0.98 | — | — |
| Jun 2027 | −$1.19 | — | — |
| Mar 2027 | −$1.21 | — | — |
| Dec 2026 | −$1.11 | — | — |
| Nov 2026 | −$1.18 | — | — |
| Aug 2026 | −$1.06 | −$1.22 | −15.1% |
| May 2026 | −$1.07 | −$1.11 | −3.7% |
| Feb 2026 | −$0.95 | −$0.94 | +1.2% |
| Nov 2025 | −$0.95 | $1.33 | +240.6% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| May 2019 | |||
| Sep 2018 | |||
| Jun 2018 | |||
| Mar 2018 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.86 | — | — | $41.1M | — | — | — |
| Sep 2027 | −$0.98 | — | — | $40.7M | — | — | — |
| Jun 2027 | −$1.19 | — | — | $15.9M | — | — | — |
| Mar 2027 | −$1.21 | — | — | $11.4M | — | — | — |
| Dec 2026 | −$1.11 | — | — | $18.0M | — | — | — |
| Nov 9, 2026 | −$1.18 | — | — | $6.8M | — | — | — |
| Aug 4, 2026 | −$1.06 | −$1.22 | −15.1% | $8.0M | $8.9M | +10.4% | +2.0% |
| May 5, 2026 | −$1.07 | −$1.11 | −3.7% | $5.0M | $6.6M | +30.2% | −0.4% |
| Feb 17, 2026 | −$0.95 | −$0.94 | +1.2% | $6.3M | $10.9M | +72.5% | +1.6% |
| Nov 4, 2025 | −$0.95 | $1.33 | +240.6% | $5.9M | $207.8M | +3,395.1% | −2.8% |
| Aug 5, 2025 | |||||||
| May 6, 2025 | |||||||
| Feb 13, 2025 | |||||||
| Nov 4, 2024 | |||||||
| Aug 6, 2024 | |||||||
| May 7, 2024 | |||||||
| Feb 20, 2024 | |||||||
| Nov 7, 2023 | |||||||
| Aug 10, 2023 | |||||||
| May 9, 2023 | |||||||
| Mar 7, 2023 | |||||||
| Nov 8, 2022 | |||||||
| Aug 15, 2022 | |||||||
| May 10, 2022 | |||||||
| Mar 15, 2022 | |||||||
| Nov 15, 2021 | |||||||
| Aug 10, 2021 | |||||||
| May 10, 2021 | |||||||
| Mar 23, 2021 | |||||||
| Nov 12, 2020 | |||||||
| Aug 12, 2020 | |||||||
| May 12, 2020 | |||||||
| Mar 24, 2020 | |||||||
| Nov 13, 2019 | |||||||
| Aug 12, 2019 | |||||||
| May 28, 2019 | |||||||
| May 24, 2019 | |||||||
| Sep 30, 2018 | |||||||
| Jun 30, 2018 | |||||||
| Mar 31, 2018 |